[Definition of malignant histiocytosis and large cell anaplastic (Ki-1) lymphoma in children]

Klin Padiatr. 1989 Jul-Aug;201(4):233-6. doi: 10.1055/s-2007-1025309.
[Article in German]

Abstract

Cells belonging to the mononuclear phagocytic system may give rise to a wide variety of proliferative disorders. These neoplastic or reactive diseases of monocytes, histiocytes and macrophages are still poorly understood, both from a biological, clinical and pathological point of view. In 1984 a new type of non-Hodgkin's lymphomas has been described, which recently was termed large cell anaplastic lymphoma (LCAL). Since both "true" malignant histiocytosis (MH) and LCAL display some clinico-pathological similarities, we reevaluated eleven children with the primary diagnosis of MH, who entered the multicentric therapy study DAL-HX 83. On the basis of the typical morphology LCAL and not MH has been diagnosed in all cases. The Ki-1 (CD 30) positive tumor cells of LCAL can display different phenotypes, either T-lymphoid, B-lymphoid, histiocytic or neither of them (O-phenotype). Therefore we investigated the lineage specificity of tumor cells in 15 paediatric patients with LCAL. Tumor cells of histiocytic origin could be demonstrated in only one of them. In 7 patients the neoplastic cells were of T cell and in the remaining 7 cases of non T/non B cell (O) phenotypes, confirming the extreme rarity of MH in children. It is our opinion that MH and LCAL seem to be different diseases not only nosologically but also clinico-pathologically. In the multicentric therapy studies NHL-BFM 81 and NHL-BFM 83 the frequency of LCAL in childhood is compared to all other subentities at 3%.

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Antibodies, Monoclonal
  • Antigens, Differentiation / analysis*
  • Antigens, Neoplasm / analysis*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • B-Lymphocytes / pathology
  • Child
  • Child, Preschool
  • Clinical Trials as Topic
  • Histiocytoma, Benign Fibrous / drug therapy
  • Histiocytoma, Benign Fibrous / pathology*
  • Humans
  • Immunohistochemistry
  • Ki-1 Antigen
  • Lymph Nodes / pathology
  • Lymphoma, Non-Hodgkin / drug therapy
  • Lymphoma, Non-Hodgkin / pathology*
  • T-Lymphocytes / pathology

Substances

  • Antibodies, Monoclonal
  • Antigens, Differentiation
  • Antigens, Neoplasm
  • Ki-1 Antigen